Advances in the basic and clinical applications of thymosin β4

Goldstein AL, Kleinman HK · Expert Opinion on Biological Therapy

Human trials of pharmaceutical Tβ4 (RegeneRx) target eyes, skin wounds, and heart — none target tendon, ligament, or cartilage; musculoskeletal use remains hypothetical.

Population

Review of thymosin β4 preclinical and clinical programs

Intervention

n/a

Comparator

n/a

Limitations

Authors hold thymosin-related patents/interests; review predates any orthopedic trial (none has appeared since).